

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | thrombin receptor signaling pathway (GO:0070493) | 7.88623471 |
| 2 | neutrophil activation involved in immune response (GO:0002283) | 7.34823173 |
| 3 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.40274501 |
| 4 | adenosine receptor signaling pathway (GO:0001973) | 6.37121424 |
| 5 | regulation of platelet aggregation (GO:0090330) | 6.06216042 |
| 6 | regulation of platelet activation (GO:0010543) | 6.00407321 |
| 7 | negative regulation of norepinephrine secretion (GO:0010700) | 5.87905883 |
| 8 | platelet aggregation (GO:0070527) | 5.68705770 |
| 9 | blood coagulation, intrinsic pathway (GO:0007597) | 5.59762696 |
| 10 | regulation of integrin-mediated signaling pathway (GO:2001044) | 5.54600250 |
| 11 | low-density lipoprotein particle remodeling (GO:0034374) | 5.31215093 |
| 12 | leukocyte migration involved in inflammatory response (GO:0002523) | 5.30479546 |
| 13 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 5.22071905 |
| 14 | negative regulation of platelet activation (GO:0010544) | 5.20847834 |
| 15 | negative regulation of heart rate (GO:0010459) | 5.18644245 |
| 16 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 5.17977730 |
| 17 | negative regulation of thymocyte apoptotic process (GO:0070244) | 4.93712191 |
| 18 | regulation of Golgi to plasma membrane protein transport (GO:0042996) | 4.93390018 |
| 19 | positive regulation of endothelial cell differentiation (GO:0045603) | 4.78875481 |
| 20 | lipoxygenase pathway (GO:0019372) | 4.63459984 |
| 21 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 4.61916653 |
| 22 | megakaryocyte development (GO:0035855) | 4.55131800 |
| 23 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 4.47467018 |
| 24 | regulation of integrin activation (GO:0033623) | 4.43627883 |
| 25 | negative regulation of response to food (GO:0032096) | 4.36944345 |
| 26 | negative regulation of appetite (GO:0032099) | 4.36944345 |
| 27 | platelet degranulation (GO:0002576) | 4.34980094 |
| 28 | platelet formation (GO:0030220) | 4.28143847 |
| 29 | positive regulation of mast cell activation (GO:0033005) | 4.25383941 |
| 30 | fusion of sperm to egg plasma membrane (GO:0007342) | 4.23784743 |
| 31 | negative regulation of protein localization to cell surface (GO:2000009) | 4.12261771 |
| 32 | neutrophil activation (GO:0042119) | 4.09388167 |
| 33 | beta-amyloid metabolic process (GO:0050435) | 4.08717153 |
| 34 | angiogenesis involved in wound healing (GO:0060055) | 4.06637080 |
| 35 | regulation of lipoprotein metabolic process (GO:0050746) | 4.02495058 |
| 36 | positive regulation of systemic arterial blood pressure (GO:0003084) | 3.98375058 |
| 37 | positive regulation of macrophage differentiation (GO:0045651) | 3.95049231 |
| 38 | positive regulation of Rho protein signal transduction (GO:0035025) | 3.92255180 |
| 39 | negative regulation of heart contraction (GO:0045822) | 3.90345319 |
| 40 | G-protein coupled purinergic receptor signaling pathway (GO:0035588) | 3.90119921 |
| 41 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 3.88613242 |
| 42 | negative regulation of hematopoietic progenitor cell differentiation (GO:1901533) | 3.87091888 |
| 43 | polyamine biosynthetic process (GO:0006596) | 3.86663446 |
| 44 | homotypic cell-cell adhesion (GO:0034109) | 3.79639438 |
| 45 | platelet activation (GO:0030168) | 3.79624671 |
| 46 | purinergic receptor signaling pathway (GO:0035587) | 3.78150250 |
| 47 | positive regulation of cAMP-mediated signaling (GO:0043950) | 3.74228287 |
| 48 | microtubule depolymerization (GO:0007019) | 3.73224957 |
| 49 | negative regulation of catecholamine secretion (GO:0033604) | 3.64983153 |
| 50 | fatty acid elongation (GO:0030497) | 3.63470268 |
| 51 | high-density lipoprotein particle remodeling (GO:0034375) | 3.61345189 |
| 52 | regulation of norepinephrine secretion (GO:0014061) | 3.59769254 |
| 53 | regulation of homotypic cell-cell adhesion (GO:0034110) | 3.56083948 |
| 54 | extracellular fibril organization (GO:0043206) | 3.55858081 |
| 55 | granulocyte activation (GO:0036230) | 3.53885605 |
| 56 | long-chain fatty acid biosynthetic process (GO:0042759) | 3.53633259 |
| 57 | autophagic vacuole fusion (GO:0000046) | 3.50027879 |
| 58 | positive regulation of receptor recycling (GO:0001921) | 3.49456780 |
| 59 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 3.47926701 |
| 60 | positive regulation of hemostasis (GO:1900048) | 3.43863753 |
| 61 | positive regulation of blood coagulation (GO:0030194) | 3.43863753 |
| 62 | sequestering of actin monomers (GO:0042989) | 3.43317576 |
| 63 | negative regulation of neural precursor cell proliferation (GO:2000178) | 3.37187542 |
| 64 | mitochondrial calcium ion transport (GO:0006851) | 3.33983571 |
| 65 | reverse cholesterol transport (GO:0043691) | 3.31274237 |
| 66 | leukocyte degranulation (GO:0043299) | 3.27506830 |
| 67 | regulation of MHC class II biosynthetic process (GO:0045346) | 3.26995707 |
| 68 | vesicle targeting (GO:0006903) | 3.22368817 |
| 69 | regulation of female receptivity (GO:0045924) | 3.21315316 |
| 70 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 3.19806044 |
| 71 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.15085636 |
| 72 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.15085636 |
| 73 | regulation of cholesterol efflux (GO:0010874) | 3.14723567 |
| 74 | regulation of memory T cell differentiation (GO:0043380) | 3.13505716 |
| 75 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.11351395 |
| 76 | L-phenylalanine catabolic process (GO:0006559) | 3.11351395 |
| 77 | regulation of megakaryocyte differentiation (GO:0045652) | 3.11286387 |
| 78 | negative regulation of protein localization to plasma membrane (GO:1903077) | 3.11129115 |
| 79 | phospholipid homeostasis (GO:0055091) | 3.09211598 |
| 80 | negative regulation of T cell apoptotic process (GO:0070233) | 3.07679261 |
| 81 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 3.05973847 |
| 82 | regulation of endothelial cell differentiation (GO:0045601) | 3.05009136 |
| 83 | termination of G-protein coupled receptor signaling pathway (GO:0038032) | 3.02643231 |
| 84 | plasma membrane fusion (GO:0045026) | 3.01917034 |
| 85 | tyrosine metabolic process (GO:0006570) | 3.00080463 |
| 86 | positive regulation of coagulation (GO:0050820) | 2.99789576 |
| 87 | positive regulation of protein homodimerization activity (GO:0090073) | 2.99500172 |
| 88 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.98431660 |
| 89 | cyclooxygenase pathway (GO:0019371) | 2.96598079 |
| 90 | regulation of blood coagulation (GO:0030193) | 2.95560646 |
| 91 | regulation of hemostasis (GO:1900046) | 2.95560646 |
| 92 | termination of signal transduction (GO:0023021) | 2.94262549 |
| 93 | endothelium development (GO:0003158) | 2.93774980 |
| 94 | fibril organization (GO:0097435) | 2.90149267 |
| 95 | poly(A)+ mRNA export from nucleus (GO:0016973) | 2.89934875 |
| 96 | negative regulation of blood circulation (GO:1903523) | 2.89643571 |
| 97 | relaxation of smooth muscle (GO:0044557) | 2.85631457 |
| 98 | regulation of receptor recycling (GO:0001919) | 2.82220140 |
| 99 | positive regulation of granulocyte differentiation (GO:0030854) | 2.81850830 |
| 100 | protein neddylation (GO:0045116) | 10.5056348 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 5.32232455 |
| 2 | SCL_19346495_ChIP-Seq_HPC-7_Human | 4.59736877 |
| 3 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 4.44092067 |
| 4 | GATA1_19941826_ChIP-Seq_K562_Human | 3.69266768 |
| 5 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 3.47390019 |
| 6 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.43670469 |
| 7 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 3.21892993 |
| 8 | GATA2_19941826_ChIP-Seq_K562_Human | 3.19062803 |
| 9 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 2.87380176 |
| 10 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 2.86618018 |
| 11 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 2.61311942 |
| 12 | HTT_18923047_ChIP-ChIP_STHdh_Human | 2.57963138 |
| 13 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.54152795 |
| 14 | SPI1_23127762_ChIP-Seq_K562_Human | 2.49959443 |
| 15 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 2.49837755 |
| 16 | GATA1_22025678_ChIP-Seq_K562_Human | 2.47657186 |
| 17 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 2.47230248 |
| 18 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.46641986 |
| 19 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.37526085 |
| 20 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.29653398 |
| 21 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.22579359 |
| 22 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 2.16061408 |
| 23 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 2.15422100 |
| 24 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.14802295 |
| 25 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.09470768 |
| 26 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 2.09022506 |
| 27 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 2.08099992 |
| 28 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.86103295 |
| 29 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.84129679 |
| 30 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.83386876 |
| 31 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.76887882 |
| 32 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.76424654 |
| 33 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.73275914 |
| 34 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.69778025 |
| 35 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.68604726 |
| 36 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 1.65113377 |
| 37 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 1.58119270 |
| 38 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.57309886 |
| 39 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.55313772 |
| 40 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 1.50279289 |
| 41 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.47705565 |
| 42 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.47304229 |
| 43 | VDR_22108803_ChIP-Seq_LS180_Human | 1.45375096 |
| 44 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.44888448 |
| 45 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.43109548 |
| 46 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.38683284 |
| 47 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.37160037 |
| 48 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.33993908 |
| 49 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.33142483 |
| 50 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.31773441 |
| 51 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.31290681 |
| 52 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 1.30303612 |
| 53 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.21999990 |
| 54 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.20262279 |
| 55 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.12191189 |
| 56 | EWS_26573619_Chip-Seq_HEK293_Human | 1.10481122 |
| 57 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.09963586 |
| 58 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.09654554 |
| 59 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.07233192 |
| 60 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.07166317 |
| 61 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.07123906 |
| 62 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.06683516 |
| 63 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.06612483 |
| 64 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.06612483 |
| 65 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.04665300 |
| 66 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.02280090 |
| 67 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.00278524 |
| 68 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.99630507 |
| 69 | LMO2_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.97071681 |
| 70 | UTX_26944678_Chip-Seq_JUKART_Human | 0.96100581 |
| 71 | RUNX1_26923725_Chip-Seq_HPCs_Mouse | 0.95400201 |
| 72 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.94617127 |
| 73 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.93635425 |
| 74 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.92149439 |
| 75 | MYB_26560356_Chip-Seq_TH2_Human | 0.91273111 |
| 76 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.91046340 |
| 77 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.90213047 |
| 78 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.89972810 |
| 79 | RBPJ_21746931_ChIP-Seq_IB4_Human | 0.88085072 |
| 80 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.87974195 |
| 81 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.86918643 |
| 82 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.85414647 |
| 83 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.85081864 |
| 84 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.84341812 |
| 85 | OCT1_27270436_Chip-Seq_PROSTATE_Human | 0.84005641 |
| 86 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 0.82372666 |
| 87 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.81514626 |
| 88 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.81365074 |
| 89 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.81316253 |
| 90 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.81307480 |
| 91 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.80408513 |
| 92 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.79756333 |
| 93 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.79133746 |
| 94 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.78788563 |
| 95 | SOX2_22085726_ChIP-Seq_NPCs_Mouse | 0.78714676 |
| 96 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.78597094 |
| 97 | NFYA_21822215_ChIP-Seq_K562_Human | 0.74577682 |
| 98 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.74251312 |
| 99 | GATA3_26560356_Chip-Seq_TH2_Human | 0.73795107 |
| 100 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 0.72466445 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0008004_abnormal_stomach_pH | 5.15040955 |
| 2 | MP0003724_increased_susceptibility_to | 3.23845724 |
| 3 | MP0000465_gastrointestinal_hemorrhage | 2.90682318 |
| 4 | MP0005083_abnormal_biliary_tract | 2.66616247 |
| 5 | MP0000343_altered_response_to | 2.53331298 |
| 6 | MP0003566_abnormal_cell_adhesion | 2.26483059 |
| 7 | MP0004084_abnormal_cardiac_muscle | 2.21766438 |
| 8 | MP0009697_abnormal_copulation | 2.16881638 |
| 9 | MP0000230_abnormal_systemic_arterial | 2.14292648 |
| 10 | MP0004510_myositis | 2.14037786 |
| 11 | MP0002736_abnormal_nociception_after | 2.13954016 |
| 12 | MP0001835_abnormal_antigen_presentation | 2.09261172 |
| 13 | MP0005410_abnormal_fertilization | 2.04583966 |
| 14 | MP0005464_abnormal_platelet_physiology | 10.4169539 |
| 15 | MP0003303_peritoneal_inflammation | 1.97535942 |
| 16 | MP0008775_abnormal_heart_ventricle | 1.87580684 |
| 17 | MP0008872_abnormal_physiological_respon | 1.85127261 |
| 18 | MP0001879_abnormal_lymphatic_vessel | 1.84231544 |
| 19 | MP0003638_abnormal_response/metabolism_ | 1.79711486 |
| 20 | MP0005646_abnormal_pituitary_gland | 1.64846356 |
| 21 | MP0003828_pulmonary_edema | 1.64414739 |
| 22 | MP0004036_abnormal_muscle_relaxation | 1.63751576 |
| 23 | MP0005671_abnormal_response_to | 1.62179202 |
| 24 | MP0005167_abnormal_blood-brain_barrier | 1.60071648 |
| 25 | MP0005084_abnormal_gallbladder_morpholo | 1.59762035 |
| 26 | MP0001545_abnormal_hematopoietic_system | 1.58728826 |
| 27 | MP0005397_hematopoietic_system_phenotyp | 1.58728826 |
| 28 | MP0010155_abnormal_intestine_physiology | 1.57050133 |
| 29 | MP0002398_abnormal_bone_marrow | 1.52574995 |
| 30 | MP0005058_abnormal_lysosome_morphology | 1.48053065 |
| 31 | MP0004130_abnormal_muscle_cell | 1.44730595 |
| 32 | MP0002132_abnormal_respiratory_system | 1.43487669 |
| 33 | MP0001851_eye_inflammation | 1.41373312 |
| 34 | MP0002148_abnormal_hypersensitivity_rea | 1.41138215 |
| 35 | MP0003656_abnormal_erythrocyte_physiolo | 1.37290620 |
| 36 | MP0002877_abnormal_melanocyte_morpholog | 1.33948720 |
| 37 | MP0009763_increased_sensitivity_to | 1.29891513 |
| 38 | MP0001663_abnormal_digestive_system | 1.27857552 |
| 39 | MP0004947_skin_inflammation | 1.25952309 |
| 40 | MP0003879_abnormal_hair_cell | 1.23946852 |
| 41 | MP0000249_abnormal_blood_vessel | 1.22318173 |
| 42 | MP0005000_abnormal_immune_tolerance | 1.22092426 |
| 43 | MP0004215_abnormal_myocardial_fiber | 1.21882860 |
| 44 | MP0002733_abnormal_thermal_nociception | 1.19043127 |
| 45 | MP0004147_increased_porphyrin_level | 1.17265058 |
| 46 | MP0010329_abnormal_lipoprotein_level | 1.17050009 |
| 47 | MP0006276_abnormal_autonomic_nervous | 1.14990802 |
| 48 | MP0001968_abnormal_touch/_nociception | 1.13444114 |
| 49 | MP0000689_abnormal_spleen_morphology | 1.12393621 |
| 50 | MP0000858_altered_metastatic_potential | 1.11381669 |
| 51 | MP0008932_abnormal_embryonic_tissue | 1.09792189 |
| 52 | MP0002429_abnormal_blood_cell | 1.08401391 |
| 53 | MP0003718_maternal_effect | 1.06150669 |
| 54 | MP0002722_abnormal_immune_system | 1.03869743 |
| 55 | MP0006036_abnormal_mitochondrial_physio | 1.03313492 |
| 56 | MP0009642_abnormal_blood_homeostasis | 0.97619866 |
| 57 | MP0005666_abnormal_adipose_tissue | 0.95395136 |
| 58 | MP0002723_abnormal_immune_serum | 0.93478269 |
| 59 | MP0005501_abnormal_skin_physiology | 0.92691233 |
| 60 | MP0009333_abnormal_splenocyte_physiolog | 0.92468315 |
| 61 | MP0000358_abnormal_cell_content/ | 0.89782242 |
| 62 | MP0008874_decreased_physiological_sensi | 0.89300221 |
| 63 | MP0009765_abnormal_xenobiotic_induced | 0.89202394 |
| 64 | MP0001765_abnormal_ion_homeostasis | 0.87505317 |
| 65 | MP0001544_abnormal_cardiovascular_syste | 0.86019559 |
| 66 | MP0005385_cardiovascular_system_phenoty | 0.86019559 |
| 67 | MP0002972_abnormal_cardiac_muscle | 0.84062147 |
| 68 | MP0002452_abnormal_antigen_presenting | 0.83788015 |
| 69 | MP0006035_abnormal_mitochondrial_morpho | 0.82921980 |
| 70 | MP0003136_yellow_coat_color | 0.82313280 |
| 71 | MP0001533_abnormal_skeleton_physiology | 0.81678669 |
| 72 | MP0005381_digestive/alimentary_phenotyp | 0.81617380 |
| 73 | MP0004134_abnormal_chest_morphology | 0.81191790 |
| 74 | MP0006138_congestive_heart_failure | 0.80203659 |
| 75 | MP0000703_abnormal_thymus_morphology | 0.79389430 |
| 76 | MP0000716_abnormal_immune_system | 0.79159995 |
| 77 | MP0005409_darkened_coat_color | 0.79045309 |
| 78 | MP0000015_abnormal_ear_pigmentation | 0.77562147 |
| 79 | MP0003186_abnormal_redox_activity | 0.76859580 |
| 80 | MP0004808_abnormal_hematopoietic_stem | 0.75306850 |
| 81 | MP0005165_increased_susceptibility_to | 0.75279619 |
| 82 | MP0001800_abnormal_humoral_immune | 0.74999437 |
| 83 | MP0002420_abnormal_adaptive_immunity | 0.74778984 |
| 84 | MP0005023_abnormal_wound_healing | 0.74692335 |
| 85 | MP0005174_abnormal_tail_pigmentation | 0.74030983 |
| 86 | MP0001661_extended_life_span | 0.73937192 |
| 87 | MP0001819_abnormal_immune_cell | 0.73705394 |
| 88 | MP0003111_abnormal_nucleus_morphology | 0.72527499 |
| 89 | MP0008877_abnormal_DNA_methylation | 0.72444615 |
| 90 | MP0005187_abnormal_penis_morphology | 0.72187562 |
| 91 | MP0001845_abnormal_inflammatory_respons | 0.71016981 |
| 92 | MP0000490_abnormal_crypts_of | 0.70137211 |
| 93 | MP0002128_abnormal_blood_circulation | 0.69410524 |
| 94 | MP0009780_abnormal_chondrocyte_physiolo | 0.67768543 |
| 95 | MP0003866_abnormal_defecation | 0.67485658 |
| 96 | MP0005535_abnormal_body_temperature | 0.66776249 |
| 97 | MP0001970_abnormal_pain_threshold | 0.66588857 |
| 98 | MP0003436_decreased_susceptibility_to | 0.65937113 |
| 99 | MP0009764_decreased_sensitivity_to | 0.64591413 |
| 100 | MP0006054_spinal_hemorrhage | 0.64358739 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Increased mean platelet volume (HP:0011877) | 9.97686449 |
| 2 | Petechiae (HP:0000967) | 9.35902119 |
| 3 | Abnormal platelet volume (HP:0011876) | 9.31433309 |
| 4 | Purpura (HP:0000979) | 8.21226444 |
| 5 | Epistaxis (HP:0000421) | 7.52496217 |
| 6 | Hyperlipoproteinemia (HP:0010980) | 6.41094553 |
| 7 | Gingival bleeding (HP:0000225) | 6.30729520 |
| 8 | Abnormal platelet function (HP:0011869) | 6.04955487 |
| 9 | Impaired platelet aggregation (HP:0003540) | 6.04955487 |
| 10 | Dyschromatopsia (HP:0007641) | 5.68658552 |
| 11 | Poikilocytosis (HP:0004447) | 4.75306446 |
| 12 | Acanthocytosis (HP:0001927) | 4.71085508 |
| 13 | Abnormal pupillary function (HP:0007686) | 4.16532488 |
| 14 | Spontaneous hematomas (HP:0007420) | 4.03245502 |
| 15 | Paralysis (HP:0003470) | 3.85535927 |
| 16 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 3.84142453 |
| 17 | Conjunctival telangiectasia (HP:0000524) | 3.66277519 |
| 18 | Abnormality of the common coagulation pathway (HP:0010990) | 3.60271998 |
| 19 | Upper limb muscle weakness (HP:0003484) | 3.40337205 |
| 20 | Bruising susceptibility (HP:0000978) | 3.30100390 |
| 21 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 3.18676527 |
| 22 | Abnormal auditory evoked potentials (HP:0006958) | 3.12383063 |
| 23 | Abnormality of lateral ventricle (HP:0030047) | 2.94059774 |
| 24 | Tinnitus (HP:0000360) | 2.92150679 |
| 25 | Decreased central vision (HP:0007663) | 2.84842197 |
| 26 | Male infertility (HP:0003251) | 2.77063000 |
| 27 | Hepatosplenomegaly (HP:0001433) | 2.73087794 |
| 28 | Xanthomatosis (HP:0000991) | 2.65838279 |
| 29 | Joint swelling (HP:0001386) | 2.57172430 |
| 30 | Joint hemorrhage (HP:0005261) | 2.50083974 |
| 31 | Increased density of long bones (HP:0006392) | 2.47630161 |
| 32 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.35446741 |
| 33 | Nausea (HP:0002018) | 2.35083483 |
| 34 | Hyperthyroidism (HP:0000836) | 2.33919468 |
| 35 | Generalized aminoaciduria (HP:0002909) | 2.33560372 |
| 36 | Increased IgM level (HP:0003496) | 2.32405290 |
| 37 | Papillary thyroid carcinoma (HP:0002895) | 2.30234816 |
| 38 | Spontaneous abortion (HP:0005268) | 2.28392760 |
| 39 | Thyroid-stimulating hormone excess (HP:0002925) | 2.17850431 |
| 40 | Abnormal gallbladder physiology (HP:0012438) | 2.13045428 |
| 41 | Cholecystitis (HP:0001082) | 2.13045428 |
| 42 | Abnormality of iron homeostasis (HP:0011031) | 2.12182855 |
| 43 | Tongue fasciculations (HP:0001308) | 2.10868589 |
| 44 | Dysautonomia (HP:0002459) | 2.08755979 |
| 45 | Polycythemia (HP:0001901) | 2.03616506 |
| 46 | Ventricular fibrillation (HP:0001663) | 2.00376823 |
| 47 | Prolonged bleeding time (HP:0003010) | 11.1022647 |
| 48 | Menorrhagia (HP:0000132) | 10.0359248 |
| 49 | Biliary tract neoplasm (HP:0100574) | 1.97597431 |
| 50 | Autoimmune hemolytic anemia (HP:0001890) | 1.96028028 |
| 51 | Renal Fanconi syndrome (HP:0001994) | 1.90857504 |
| 52 | Hypophosphatemic rickets (HP:0004912) | 1.89334052 |
| 53 | 3-Methylglutaconic aciduria (HP:0003535) | 1.89101802 |
| 54 | Insidious onset (HP:0003587) | 1.88159141 |
| 55 | Termporal pattern (HP:0011008) | 1.88159141 |
| 56 | Thrombocytosis (HP:0001894) | 1.86744002 |
| 57 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.84112963 |
| 58 | Stomatitis (HP:0010280) | 1.83441244 |
| 59 | Abnormality of macrophages (HP:0004311) | 1.83318769 |
| 60 | Muscle fibrillation (HP:0010546) | 1.83233895 |
| 61 | Arterial thrombosis (HP:0004420) | 1.82402367 |
| 62 | Abnormal ciliary motility (HP:0012262) | 1.82354052 |
| 63 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.79179609 |
| 64 | Thyroid carcinoma (HP:0002890) | 1.78517277 |
| 65 | Abnormality of the prostate (HP:0008775) | 1.73264547 |
| 66 | Leiomyosarcoma (HP:0100243) | 1.71969921 |
| 67 | Uterine leiomyosarcoma (HP:0002891) | 1.71969921 |
| 68 | Ileus (HP:0002595) | 1.70634850 |
| 69 | Truncus arteriosus (HP:0001660) | 1.66475087 |
| 70 | Distal lower limb amyotrophy (HP:0008944) | 1.65288101 |
| 71 | Myocardial infarction (HP:0001658) | 1.64218445 |
| 72 | Transitional cell carcinoma of the bladder (HP:0006740) | 1.62947893 |
| 73 | Central scotoma (HP:0000603) | 1.61762583 |
| 74 | Obstructive lung disease (HP:0006536) | 1.61266910 |
| 75 | Chronic obstructive pulmonary disease (HP:0006510) | 1.61266910 |
| 76 | Back pain (HP:0003418) | 1.60937601 |
| 77 | Infertility (HP:0000789) | 1.58183447 |
| 78 | Increased serum ferritin (HP:0003281) | 1.56869696 |
| 79 | Neoplasm of the rectum (HP:0100743) | 1.56822055 |
| 80 | Testicular neoplasm (HP:0010788) | 1.56114407 |
| 81 | Abnormal spermatogenesis (HP:0008669) | 1.54858731 |
| 82 | Encephalitis (HP:0002383) | 1.50667479 |
| 83 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.49930087 |
| 84 | Episodic fever (HP:0001954) | 1.47313872 |
| 85 | Abnormal respiratory epithelium morphology (HP:0012253) | 1.47012035 |
| 86 | Abnormal respiratory motile cilium morphology (HP:0005938) | 1.47012035 |
| 87 | Exertional dyspnea (HP:0002875) | 1.46968703 |
| 88 | Bladder neoplasm (HP:0009725) | 1.45427955 |
| 89 | Bladder carcinoma (HP:0002862) | 1.45427955 |
| 90 | Vertigo (HP:0002321) | 1.44599571 |
| 91 | Amaurosis fugax (HP:0100576) | 1.42925784 |
| 92 | Abnormal large intestine physiology (HP:0012700) | 1.40581181 |
| 93 | Delayed puberty (HP:0000823) | 1.40410836 |
| 94 | Basal ganglia calcification (HP:0002135) | 1.40026656 |
| 95 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.39629635 |
| 96 | Mucosal telangiectasiae (HP:0100579) | 1.39103379 |
| 97 | Cerebral hemorrhage (HP:0001342) | 1.38704856 |
| 98 | Polyphagia (HP:0002591) | 1.38674357 |
| 99 | Hereditary nonpolyposis colorectal carcinoma (HP:0006716) | 1.38544618 |
| 100 | Myelodysplasia (HP:0002863) | 1.37170306 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MST4 | 6.39350961 |
| 2 | RIPK4 | 5.20144253 |
| 3 | EIF2AK1 | 4.44946141 |
| 4 | BMX | 4.30702750 |
| 5 | MYLK | 3.67531149 |
| 6 | TEC | 3.05582011 |
| 7 | BTK | 2.93212169 |
| 8 | PTK2B | 2.49277037 |
| 9 | PIK3CG | 2.38610493 |
| 10 | BMPR2 | 2.24427978 |
| 11 | TAOK3 | 2.18092958 |
| 12 | ILK | 2.09944346 |
| 13 | STK3 | 1.98943754 |
| 14 | SYK | 1.96716349 |
| 15 | GRK5 | 1.93760731 |
| 16 | CSF1R | 1.87909406 |
| 17 | TRIM28 | 1.79027089 |
| 18 | ZAP70 | 1.71173746 |
| 19 | PLK2 | 1.54696685 |
| 20 | FGR | 1.42724821 |
| 21 | PAK1 | 1.42021572 |
| 22 | GRK6 | 1.36985491 |
| 23 | PNCK | 1.35474856 |
| 24 | MAPKAPK3 | 1.33000624 |
| 25 | ACVR1B | 1.30732855 |
| 26 | SIK3 | 1.19649446 |
| 27 | HCK | 1.18515134 |
| 28 | BRSK2 | 1.18063978 |
| 29 | TNIK | 1.13054598 |
| 30 | MATK | 1.06481978 |
| 31 | LMTK2 | 1.02395379 |
| 32 | RET | 1.00577527 |
| 33 | LYN | 0.98540501 |
| 34 | DAPK3 | 0.96999661 |
| 35 | TLK1 | 0.96554399 |
| 36 | STK24 | 0.93552982 |
| 37 | STK4 | 0.93055474 |
| 38 | ADRBK2 | 0.88295214 |
| 39 | MARK3 | 0.87991908 |
| 40 | NUAK1 | 0.86802014 |
| 41 | ITK | 0.85233907 |
| 42 | PLK3 | 0.78968711 |
| 43 | IKBKB | 0.77962905 |
| 44 | TNK2 | 0.75628824 |
| 45 | FES | 0.75272575 |
| 46 | PIM2 | 0.73626767 |
| 47 | ZAK | 0.72242238 |
| 48 | MINK1 | 0.71394339 |
| 49 | EPHA3 | 0.68229565 |
| 50 | IRAK1 | 0.66105022 |
| 51 | MAP3K5 | 0.63517498 |
| 52 | MAP2K3 | 0.62776283 |
| 53 | FER | 0.62773550 |
| 54 | BMPR1B | 0.62581603 |
| 55 | ADRBK1 | 0.61447279 |
| 56 | PRKD1 | 0.61296952 |
| 57 | PKN1 | 0.59594183 |
| 58 | IRAK3 | 0.59458084 |
| 59 | ERBB2 | 0.57769534 |
| 60 | BLK | 0.57561729 |
| 61 | TAOK2 | 0.57377459 |
| 62 | CCNB1 | 0.56318445 |
| 63 | MAP2K1 | 0.49549445 |
| 64 | VRK1 | 0.48949804 |
| 65 | PRKACG | 0.47889220 |
| 66 | CDK8 | 0.47650824 |
| 67 | TXK | 0.45457525 |
| 68 | TESK2 | 0.45428519 |
| 69 | CDC7 | 0.44846112 |
| 70 | JAK2 | 0.44616123 |
| 71 | DAPK1 | 0.44023310 |
| 72 | RAF1 | 0.42772930 |
| 73 | PRKG1 | 0.41527263 |
| 74 | PLK4 | 0.40661530 |
| 75 | EPHB2 | 0.37991656 |
| 76 | FLT3 | 0.37232970 |
| 77 | YES1 | 0.35890293 |
| 78 | PDK1 | 0.35600745 |
| 79 | DYRK3 | 0.34969320 |
| 80 | ARAF | 0.34238310 |
| 81 | PKN2 | 0.33436402 |
| 82 | PRKCB | 0.33073496 |
| 83 | CDK14 | 0.31861988 |
| 84 | LCK | 0.30619101 |
| 85 | PAK2 | 0.29182009 |
| 86 | DAPK2 | 0.26555809 |
| 87 | FYN | 0.26409049 |
| 88 | PDGFRB | 0.26260056 |
| 89 | PRKCD | 0.25920541 |
| 90 | MAPK12 | 0.24673361 |
| 91 | JAK3 | 0.22970095 |
| 92 | IGF1R | 0.21284374 |
| 93 | AURKA | 0.20871548 |
| 94 | PRKCQ | 0.20610683 |
| 95 | ROCK1 | 0.19824312 |
| 96 | PRKCA | 0.19723372 |
| 97 | MKNK1 | 0.19291794 |
| 98 | PIM1 | 0.18687707 |
| 99 | SRC | 0.18435572 |
| 100 | CSK | 0.18074432 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Platelet activation_Homo sapiens_hsa04611 | 6.10042985 |
| 2 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 4.26680320 |
| 3 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 3.68523748 |
| 4 | Mismatch repair_Homo sapiens_hsa03430 | 2.92724183 |
| 5 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 2.68112786 |
| 6 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.59984032 |
| 7 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 2.22586723 |
| 8 | ECM-receptor interaction_Homo sapiens_hsa04512 | 2.18653569 |
| 9 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.15474699 |
| 10 | Gap junction_Homo sapiens_hsa04540 | 2.14505990 |
| 11 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.93055303 |
| 12 | Alcoholism_Homo sapiens_hsa05034 | 1.91260960 |
| 13 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.90996755 |
| 14 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.88991654 |
| 15 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.79379118 |
| 16 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.73682106 |
| 17 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.70052887 |
| 18 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.54095930 |
| 19 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.40416665 |
| 20 | Shigellosis_Homo sapiens_hsa05131 | 1.39148545 |
| 21 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.30831221 |
| 22 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.30532596 |
| 23 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.30266705 |
| 24 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.30257528 |
| 25 | Endocytosis_Homo sapiens_hsa04144 | 1.26380249 |
| 26 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 1.20562593 |
| 27 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.16164048 |
| 28 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.14302057 |
| 29 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.11884729 |
| 30 | Olfactory transduction_Homo sapiens_hsa04740 | 1.08861920 |
| 31 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.03587245 |
| 32 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.01402327 |
| 33 | Long-term depression_Homo sapiens_hsa04730 | 0.93904252 |
| 34 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.93778350 |
| 35 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.91246316 |
| 36 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.91011489 |
| 37 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.89238701 |
| 38 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.89009457 |
| 39 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.88203095 |
| 40 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.87371492 |
| 41 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.86645256 |
| 42 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.81257128 |
| 43 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.79994030 |
| 44 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.76496037 |
| 45 | DNA replication_Homo sapiens_hsa03030 | 0.75180833 |
| 46 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.74139779 |
| 47 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.74086603 |
| 48 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.73839950 |
| 49 | Focal adhesion_Homo sapiens_hsa04510 | 0.73299321 |
| 50 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.72893866 |
| 51 | Circadian entrainment_Homo sapiens_hsa04713 | 0.72469904 |
| 52 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.70924256 |
| 53 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.69288650 |
| 54 | Endometrial cancer_Homo sapiens_hsa05213 | 0.68486737 |
| 55 | Melanoma_Homo sapiens_hsa05218 | 0.68424877 |
| 56 | Thyroid cancer_Homo sapiens_hsa05216 | 0.67837902 |
| 57 | Purine metabolism_Homo sapiens_hsa00230 | 0.67325625 |
| 58 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.65507201 |
| 59 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.64919480 |
| 60 | Glioma_Homo sapiens_hsa05214 | 0.64821509 |
| 61 | Morphine addiction_Homo sapiens_hsa05032 | 0.64332914 |
| 62 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.62122944 |
| 63 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.61496041 |
| 64 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.61184263 |
| 65 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.58591214 |
| 66 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.58480911 |
| 67 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.57080501 |
| 68 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.53976556 |
| 69 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.52127950 |
| 70 | Cell cycle_Homo sapiens_hsa04110 | 0.50174404 |
| 71 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.49553003 |
| 72 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.49166986 |
| 73 | Homologous recombination_Homo sapiens_hsa03440 | 0.48928432 |
| 74 | Phagosome_Homo sapiens_hsa04145 | 0.48786778 |
| 75 | GABAergic synapse_Homo sapiens_hsa04727 | 0.48630655 |
| 76 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.48538865 |
| 77 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.48333717 |
| 78 | Malaria_Homo sapiens_hsa05144 | 0.46430290 |
| 79 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.46249748 |
| 80 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.43339642 |
| 81 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.42754157 |
| 82 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.42257196 |
| 83 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.41978425 |
| 84 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.40827440 |
| 85 | Phototransduction_Homo sapiens_hsa04744 | 0.40179919 |
| 86 | Galactose metabolism_Homo sapiens_hsa00052 | 0.37991039 |
| 87 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.36115980 |
| 88 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.36067944 |
| 89 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.34844287 |
| 90 | Apoptosis_Homo sapiens_hsa04210 | 0.32418616 |
| 91 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.31823542 |
| 92 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.29532527 |
| 93 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.29431995 |
| 94 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.28631998 |
| 95 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.27859689 |
| 96 | Legionellosis_Homo sapiens_hsa05134 | 0.27525939 |
| 97 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.27193087 |
| 98 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.26185184 |
| 99 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.22887798 |
| 100 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.22882162 |

